Caseware UK (AP4) 2023.0.135 2023.0.135 2024-06-302024-06-30Manufacture of other inorganic basic chemicals, Manufacture of other organic basic chemicals, Manufacture of other chemical products not elsewhere classified, Other research and experimental development on natural sciences and engineering2023-07-01false103falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 14154914 2023-07-01 2024-06-30 14154914 2022-06-07 2023-06-30 14154914 2024-06-30 14154914 2023-06-30 14154914 1 2023-07-01 2024-06-30 14154914 d:Director3 2023-07-01 2024-06-30 14154914 c:OfficeEquipment 2023-07-01 2024-06-30 14154914 c:OfficeEquipment 2024-06-30 14154914 c:OfficeEquipment 2023-06-30 14154914 c:OfficeEquipment c:OwnedOrFreeholdAssets 2023-07-01 2024-06-30 14154914 c:ComputerEquipment 2023-07-01 2024-06-30 14154914 c:ComputerEquipment 2024-06-30 14154914 c:ComputerEquipment 2023-06-30 14154914 c:ComputerEquipment c:OwnedOrFreeholdAssets 2023-07-01 2024-06-30 14154914 c:OwnedOrFreeholdAssets 2023-07-01 2024-06-30 14154914 c:CurrentFinancialInstruments 2024-06-30 14154914 c:CurrentFinancialInstruments 2023-06-30 14154914 c:CurrentFinancialInstruments c:WithinOneYear 2024-06-30 14154914 c:CurrentFinancialInstruments c:WithinOneYear 2023-06-30 14154914 c:ShareCapital 2024-06-30 14154914 c:ShareCapital 2023-06-30 14154914 c:SharePremium 2024-06-30 14154914 c:SharePremium 2023-06-30 14154914 c:RetainedEarningsAccumulatedLosses 2024-06-30 14154914 c:RetainedEarningsAccumulatedLosses 2023-06-30 14154914 d:OrdinaryShareClass1 2023-07-01 2024-06-30 14154914 d:OrdinaryShareClass1 2024-06-30 14154914 d:OrdinaryShareClass1 2023-06-30 14154914 d:OrdinaryShareClass2 2023-07-01 2024-06-30 14154914 d:OrdinaryShareClass2 2024-06-30 14154914 d:OrdinaryShareClass2 2023-06-30 14154914 d:FRS102 2023-07-01 2024-06-30 14154914 d:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 14154914 d:FullAccounts 2023-07-01 2024-06-30 14154914 d:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 14154914 c:WithinOneYear 2024-06-30 14154914 c:WithinOneYear 2023-06-30 14154914 c:BetweenOneFiveYears 2024-06-30 14154914 c:BetweenOneFiveYears 2023-06-30 14154914 e:PoundSterling 2023-07-01 2024-06-30 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 14154914










FLUOROK LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 JUNE 2024

 
FLUOROK LIMITED
REGISTERED NUMBER: 14154914

BALANCE SHEET
AS AT 30 JUNE 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
591,401
371,152

  
591,401
371,152

Current assets
  

Debtors: amounts falling due within one year
 5 
374,290
615,547

Cash at bank and in hand
 6 
926,245
1,362,792

  
1,300,535
1,978,339

Current liabilities
  

Creditors: amounts falling due within one year
 7 
(775,342)
(84,051)

Net current assets
  
 
 
525,193
 
 
1,894,288

Total assets less current liabilities
  
1,116,594
2,265,440

  

Net assets
  
1,116,594
2,265,440


Capital and reserves
  

Called up share capital 
 8 
2
2

Share premium account
  
3,000,000
3,000,000

Profit and loss account
  
(1,883,408)
(734,562)

  
1,116,594
2,265,440


Page 1

 
FLUOROK LIMITED
REGISTERED NUMBER: 14154914

BALANCE SHEET (CONTINUED)
AS AT 30 JUNE 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




G Pupo
Director

Date: 11 November 2024

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
FLUOROK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

1.


General information

Fluorok Limited is a private company limited by share capital and incorporated in England and Wales.
The registered office is Ground Floor, 7400 The Quorum, Alec Issigonis Way, Oxford, OX4 2JZ.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.
Grants of a revenue nature are recognised in the Statement of Comprehensive Income in the same period as the related expenditure.

 
2.3

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 3

 
FLUOROK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)


2.5
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Lab equipment
-
7 years
Computer equipment
-
4 years

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

2024
2023
£
£

Wages and salaries
516,202
195,469

Social security costs
53,964
17,291

Cost of defined contribution scheme
33,479
10,399

603,645
223,159


The average monthly number of employees, including directors, during the year was 10 (2023 - 3).

Page 4

 
FLUOROK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

4.


Tangible fixed assets





Lab equipment
Computer equipment
Total

£
£
£



Cost or valuation


At 1 July 2023
399,091
3,902
402,993


Additions
302,209
9,389
311,598


Disposals
(1,745)
(114)
(1,859)



At 30 June 2024

699,555
13,177
712,732



Depreciation


At 1 July 2023
31,247
594
31,841


Charge for the year on owned assets
87,266
2,341
89,607


Disposals
(96)
(21)
(117)



At 30 June 2024

118,417
2,914
121,331



Net book value



At 30 June 2024
581,138
10,263
591,401



At 30 June 2023
367,844
3,308
371,152

Page 5

 
FLUOROK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

5.


Debtors

2024
2023
£
£


Other debtors
126,448
528,609

Prepayments and accrued income
101,531
30,469

Tax recoverable
146,311
56,469

374,290
615,547



6.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
926,245
1,362,792

926,245
1,362,792



7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
146,219
58,922

Other taxation and social security
18,569
14,249

Other creditors
608,135
3,235

Accruals and deferred income
2,419
7,645

775,342
84,051


Other creditors consist of a convertible loan of £600,000 (2023: £nil) and pensions payable of £8,135 (2023: £3,235). The convertible loan was short term funding and converted to equity in July 2024.

Page 6

 
FLUOROK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

8.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



1,000,000 (2023 - 1,000,000) Ordinary shares of £0.000001 each
1
1
779,221 (2023 - 779,221) Seed shares of £0.000001 each
1
1

2

2



9.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company  in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £33,479 (2023: £22,327). Contributions totalling £8,135 (2023: £3,235) were payable to the fund at the balance sheet date and are included in creditors.


10.


Commitments under operating leases

At 30 June 2024 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2024
2023
£
£


Not later than 1 year
40,253
2,800

Later than 1 year and not later than 5 years
644,040
-

684,293
2,800


11.


Post balance sheet events

On 23 July 2024, 1,510,331 Ordinary A shares of £0.000001 were issued for the total consideration of £7,747,998, including £600,000 converted from a loan.


Page 7